Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Uxin (UXIN) Notes Payables (2017 - 2025)

Uxin filings provide 8 years of Notes Payables readings, the most recent being $56.0 million for Q4 2025.

  • On a quarterly basis, Notes Payables rose 130.35% to $56.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.0 million, a 130.35% increase, with the full-year FY2025 number at $56.8 million, up 137.41% from a year prior.
  • Notes Payables hit $56.0 million in Q4 2025 for Uxin, up from $30.9 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $56.0 million in Q4 2025 to a low of $2900.0 in Q4 2022.
  • Median Notes Payables over the past 4 years was $2.0 million (2023), compared with a mean of $14.4 million.
  • The widest YoY moves for Notes Payables: up 259116.17% in 2024, down 66.51% in 2024.
  • Uxin's Notes Payables stood at $2900.0 in 2022, then skyrocketed by 223.38% to $9378.0 in 2023, then soared by 259116.17% to $24.3 million in 2024, then soared by 130.35% to $56.0 million in 2025.
  • The last three reported values for Notes Payables were $56.0 million (Q4 2025), $30.9 million (Q2 2025), and $24.3 million (Q4 2024) per Business Quant data.